Simple Plans
AI in Safety Compliance Special Report
Simple Plans
AI in Safety Compliance Special Report
Simple Plans
AI in Safety Compliance Special Report
This AI in Safety & Compliance Competitive Intelligence report is not part of a recurring subscription — and that’s intentional.
Unlike lightweight CI briefs or trend memos, this report is a comprehensive, 87-page analysis built over months of competitive mapping, regulatory tracking, and strategic modeling. It captures a transitional moment in the life sciences and AI safety ecosystem — a point-in-time snapshot that is unlikely to repeat in form or depth.
We created it as a standalone strategic asset:
Not a teaser
Not a summary
But a complete reference designed to support decision-making, internal presentations, or investment conversations.
While LucidBio will continue to release future intelligence products, none are planned to replicate the scale or structure of this foundational piece. Ongoing updates and CI toolkits may become available through future subscription models, but this report will remain a single-issue, premium publication.
Micro
Full toolkits, sector briefs, 1-hour consult
Micro
Full toolkits, sector briefs, 1-hour consult
Starter
Small team exploration, useful for early validation
Starter
Small team exploration, useful for early validation
Micro Tier
Low-barrier entry, visibility into strategic framing
Starter
Small team exploration, useful for early validation
Micro Tier
Low-barrier entry, visibility into stategic framing
Starter
Small team exploration, useful for early validation
Micro Tier
Low-barrier entry, visibility into stategic framing
Snapshot
Bridges Starter and Growth; gives more depth without consulting features
Starter
Small team exploration, useful for early validation
Snapshot
Bridges Starter and Growth; gives more depth without consulting features
Starter
Small team exploration, useful for early validation
Growth
Adds consult, vendor positioning analysis, and initial tool access
Snapshot
Bridges Starter and Grwoth; gives more depth without consulting features
Advanced
Full toolkits, sector briefs, 1-hour consult
Advanced
Full toolkits, sector briefs, 1-hour consult
Premium
Everything + internal licensing and strategy briefings
Premium
Everything + internal licensing and strategy briefings
Growth
Adds consult, vendor positioning analysis, and initial tool access
Growth
Adds consult, vendor positioning analysis, and initial tool access
All Features
Compare Between Plans
All Features
Compare Between Plans
All Features
Compare Between Plans
Subscription
Tiers
Micro £50/mo
Starter £250/mo
Snapshot £750/mo
Growth £2500/mo
Advanced
Premium
Executive Summary (6 pages)
✔️ + Key trends & statistics
✔️
✔️
✔️
✔️
✔️
Curated Pages from Main Report
✔️ + 2 Sector-specific use cases
15 pgs
20-30 pgs
60 pgs
87 pgs
Vendor Segmentation Charts
✔️
✔️
✔️
✔️
Regulatory Signal Summary
✔️
✔️
✔️
✔️
Company-Level Vendor Analysis
✔️
✔️
✔️
AI Risk Checklist
Sample
Full
Full
Vendor Mapping Grid
✔️
✔️
✔️
✔️
ROI & Strategic Trend Charts
✔️
✔️
✔️
Strategic Alignment Matrix
✔️
✔️
Sector-Specific Intelligence Brief
2 actionable insights
5 actionable insights
✔️
✔️
✔️
Internal Use License of LucidBio Tools
5 AI Tool Insights
10 AI Tool Insights
✔️
Expert Consultation
15 m
1 hr
2 hrs
4 hrs
Our pricing table is best viewed on a desktop device. Please visit this page on a desktop browser to see a complete comparison of all subscription tiers and features.
Our pricing table is best viewed on a desktop device. Please visit this page on a desktop browser to see a complete comparison of all subscription tiers and features.
FAQs
Frequently Asked Questions
FAQs
Frequently Asked Questions
FAQs
Frequently Asked Questions
How is this different from enterprise platforms like AlphaSense or Cortellis?
Enterprise platforms provide self-service database access—you search and analyze yourself. We provide analyst-driven strategic intelligence—human experts who deliver insights and recommendations specific to your needs. Think of us as your fractional CI team, not a software subscription.
What’s shifting in the landscape — and why should I care now?
Because timing matters. We track not just competitor actions, but the strategic meaning behind them.
How do you gather competitive intelligence?
We analyze publicly available sources including ClinicalTrials.gov, regulatory databases, scientific publications, company press releases, investor presentations, and conference proceedings. All work is conducted ethically and legally. We never use corporate espionage or questionable methods.
Can I use these reports in investor materials?
Yes. The reports are yours to use as you see fit—in pitch decks, board presentations, or strategic planning documents. We can also format deliverables to match your investor deck style upon request.
What if my competitors are private companies with limited information?
We specialize in piecing together intelligence from fragmentary sources. Even private biotechs leave digital footprints through trial registries, publications, patents, job postings, and conference presentations. This is where analyst expertise matters—connecting the dots that platforms miss.
How long does it take to get a competitive intelligence report?
One-time reports: 2 weeks from kickoff to final delivery, including a 60-minute strategy debrief call. Free competitive briefs: 3-5 business days. Monthly subscriptions: Initial setup takes 1-2 weeks, then you receive ongoing briefings on your chosen schedule (weekly, bi-weekly, or monthly). We prioritize speed without sacrificing quality—perfect for biotech teams working against tight timelines.
What if I'm not sure which service I need?
Start with our free 1-page competitive brief. This gives you a taste of our analysis style and helps us understand your specific needs. Based on that initial brief, we can recommend whether a one-time report, monthly subscription, or custom project makes the most sense for your situation. No pressure, no obligation—we'd rather recommend the right fit than oversell.
Do you work with companies outside the UK?
Yes, we have operations in UK & US. We work with biotech companies globally—UK, EU, US, Canada, and beyond. Our intelligence coverage is international (we track FDA, EMA, PMDA, and other regulatory bodies), and we deliver reports remotely via video calls and digital documents. Time zone differences are never an issue—we schedule debriefs at times that work for your team.
How is this different from enterprise platforms like AlphaSense or Cortellis?
Enterprise platforms provide self-service database access—you search and analyze yourself. We provide analyst-driven strategic intelligence—human experts who deliver insights and recommendations specific to your needs. Think of us as your fractional CI team, not a software subscription.
What’s shifting in the landscape — and why should I care now?
Because timing matters. We track not just competitor actions, but the strategic meaning behind them.
How do you gather competitive intelligence?
We analyze publicly available sources including ClinicalTrials.gov, regulatory databases, scientific publications, company press releases, investor presentations, and conference proceedings. All work is conducted ethically and legally. We never use corporate espionage or questionable methods.
Can I use these reports in investor materials?
Yes. The reports are yours to use as you see fit—in pitch decks, board presentations, or strategic planning documents. We can also format deliverables to match your investor deck style upon request.
What if my competitors are private companies with limited information?
We specialize in piecing together intelligence from fragmentary sources. Even private biotechs leave digital footprints through trial registries, publications, patents, job postings, and conference presentations. This is where analyst expertise matters—connecting the dots that platforms miss.
How long does it take to get a competitive intelligence report?
One-time reports: 2 weeks from kickoff to final delivery, including a 60-minute strategy debrief call. Free competitive briefs: 3-5 business days. Monthly subscriptions: Initial setup takes 1-2 weeks, then you receive ongoing briefings on your chosen schedule (weekly, bi-weekly, or monthly). We prioritize speed without sacrificing quality—perfect for biotech teams working against tight timelines.
What if I'm not sure which service I need?
Start with our free 1-page competitive brief. This gives you a taste of our analysis style and helps us understand your specific needs. Based on that initial brief, we can recommend whether a one-time report, monthly subscription, or custom project makes the most sense for your situation. No pressure, no obligation—we'd rather recommend the right fit than oversell.
Do you work with companies outside the UK?
Yes, we have operations in UK & US. We work with biotech companies globally—UK, EU, US, Canada, and beyond. Our intelligence coverage is international (we track FDA, EMA, PMDA, and other regulatory bodies), and we deliver reports remotely via video calls and digital documents. Time zone differences are never an issue—we schedule debriefs at times that work for your team.
How is this different from enterprise platforms like AlphaSense or Cortellis?
Enterprise platforms provide self-service database access—you search and analyze yourself. We provide analyst-driven strategic intelligence—human experts who deliver insights and recommendations specific to your needs. Think of us as your fractional CI team, not a software subscription.
What’s shifting in the landscape — and why should I care now?
Because timing matters. We track not just competitor actions, but the strategic meaning behind them.
How do you gather competitive intelligence?
We analyze publicly available sources including ClinicalTrials.gov, regulatory databases, scientific publications, company press releases, investor presentations, and conference proceedings. All work is conducted ethically and legally. We never use corporate espionage or questionable methods.
Can I use these reports in investor materials?
Yes. The reports are yours to use as you see fit—in pitch decks, board presentations, or strategic planning documents. We can also format deliverables to match your investor deck style upon request.
What if my competitors are private companies with limited information?
We specialize in piecing together intelligence from fragmentary sources. Even private biotechs leave digital footprints through trial registries, publications, patents, job postings, and conference presentations. This is where analyst expertise matters—connecting the dots that platforms miss.
How long does it take to get a competitive intelligence report?
One-time reports: 2 weeks from kickoff to final delivery, including a 60-minute strategy debrief call. Free competitive briefs: 3-5 business days. Monthly subscriptions: Initial setup takes 1-2 weeks, then you receive ongoing briefings on your chosen schedule (weekly, bi-weekly, or monthly). We prioritize speed without sacrificing quality—perfect for biotech teams working against tight timelines.
What if I'm not sure which service I need?
Start with our free 1-page competitive brief. This gives you a taste of our analysis style and helps us understand your specific needs. Based on that initial brief, we can recommend whether a one-time report, monthly subscription, or custom project makes the most sense for your situation. No pressure, no obligation—we'd rather recommend the right fit than oversell.
Do you work with companies outside the UK?
Yes, we have operations in UK & US. We work with biotech companies globally—UK, EU, US, Canada, and beyond. Our intelligence coverage is international (we track FDA, EMA, PMDA, and other regulatory bodies), and we deliver reports remotely via video calls and digital documents. Time zone differences are never an issue—we schedule debriefs at times that work for your team.
Get Started
Ready To Gain An Edge On A Volatile Life Science Landscape
AI in Safety Compliance Competitive Intelligence Report
Get Started
Ready To Gain An Edge On A Volatile Life Science Landscape
AI in Safety Compliance Competitive Intelligence Report
Get Started
Ready To Gain An Edge On A Volatile Life Science Landscape
AI in Safety Compliance Competitive Intelligence Report